Javed Anees/LinkedIn
Jun 18, 2026, 02:07
Javed Anees: ATA 2026 Guidelines – A New Era in Thyroid Care During Pregnancy
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“ATA 2026 Guidelines: A New Era in Thyroid Care During Pregnancy
The American Thyroid Association (ATA) 2026 Guidelines introduce important updates in the management of thyroid disease during preconception, pregnancy, and postpartum care.
- The traditional universal TSH 2.5 mIU/L first-trimester cutoff is no longer recommended
- Greater emphasis on trimester-specific, population-specific, and laboratory-specific reference ranges
- TSH >4.0 mIU/L is generally considered abnormal when pregnancy-specific ranges are unavailable
- All overt hypothyroidism should be treated with levothyroxine
- Women already receiving levothyroxine should increase the dose by approximately 20–30% once pregnancy is confirmed
- Routine levothyroxine is not recommended for euthyroid, TPO-antibody–positive women with infertility
- New focus on avoiding overtreatment, individualized care, and shared decision-making
- Updated guidance on Graves disease, antithyroid drug selection, postpartum thyroiditis, and postpartum dose adjustment
The central message is clear: precision medicine has replaced one-size-fits-all thyroid management in pregnancy.
Understanding these updates is essential for physicians involved in Internal Medicine, Endocrinology, Obstetrics, Family Medicine, and Maternal–Fetal Medicine.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
ATA 2026 Guidelines
Endocrinology
Family Medicine
Fertility
Fertility News
Graves disease
hypothyroidism
individualized care
infertility
Internal medicine
Javed Anees
laboratory-specific
Levothyroxine
Maternal Fetal Medicine
Obstetrics
population-specific
postpartum thyroiditis
pregnancy
reproductive health
Reproductive Medicine
The American Thyroid Association (ATA)
Thyroid Care
TPO-antibody–positive
trimester-specific
TSH
-
Jun 18, 2026, 02:58Outstanding Challenges in Maternal–Perinatal Health – FIGO
-
Jun 18, 2026, 02:11Understanding the Risks of Unregulated Sperm Donation – HFEA
-
Jun 17, 2026, 11:17Asma Khalil: Preconception Health Remains One of the Most Underutilised Opportunities
-
Jun 17, 2026, 11:08Marco Zaccaria: Enhanced Myometrial Vascularity: Ultrasound Findings and Clinical Context
-
Jun 17, 2026, 11:01Femi Oladapo: Global Pre-eclampsia Summit: Aligning Priorities for Impact
-
Jun 17, 2026, 10:51Christopher Robinson: Isolated Fetal Ventricular Septal Defect and Chromosomal-Genomic Abnormalities!
-
Jun 17, 2026, 10:47New Evidence on Recurrent Implantation Failure – ESHRE
-
Jun 17, 2026, 10:44Timed Intercourse and Fertile Window Monitoring: What the Data Shows – Fertility Plus
-
Jun 16, 2026, 15:50Christopher Robinson: Chronic Histiocytic Intervillositis of the Placenta: Clinical Outcomes and Doppler Associations
